BBWI
BATH & BODY WORKS, INC.Marquee-fund ownership over time
This quarter's activity
New positions opened
None.
Positions exited
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies re-entered | Q3 2024(8Q snapshot) | 7Q | $30 | $16 | -46% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $30 | $16 | -46% |
| Two Sigma Investments re-entered | Q3 2024(8Q snapshot) | 7Q | $30 | $16 | -46% |
| D.E. Shaw re-entered | Q3 2024(8Q snapshot) | 7Q | $30 | $16 | -46% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $30 | $16 | -46% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $30 | $16 | -46% |
| Point72 Asset Management | Q3 2024(8Q snapshot) | 7Q | $30 | $16 | -46% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Bridgewater Associates 2× in & out | Q2 2024 | Q2 2026 | → $17 | -63% |
| Maverick Capital 6× in & out | Q4 2025 | Q1 2026 | → $24 | +11% |
| D1 Capital Partners 2× in & out | Q1 2025 | Q3 2025 | → $28 | -20% |
| Third Point | Q4 2022 | Q1 2025 | → $35 | +16% |
| Lone Pine Capital | Q4 2021 | Q4 2024 | → $30 | -56% |
| Coatue Management | Q4 2021 | Q2 2023 | → $31 | -54% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Bath & Body Works, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 20, 2026 — the most recent Form 4 on file — not from today.
- Form 40001225208-26-005504May 20, 2026
- Form 40001225208-26-005481May 19, 2026
- Form 40001225208-26-003713Mar 16, 2026
- Form 40001225208-26-003712Mar 16, 2026
- Form 40001225208-26-003711Mar 16, 2026
- Form 40001225208-25-009449Nov 25, 2025
- Form 40001225208-25-009448Nov 25, 2025
- Form 40001225208-25-009414Nov 24, 2025
- Form 40001225208-25-009413Nov 24, 2025
- Form 40001225208-25-009412Nov 24, 2025
- Form 40001225208-25-009411Nov 24, 2025
- Form 40001225208-25-007016Aug 5, 2025
- Form 40001225208-25-005819Jun 9, 2025
- Form 40001225208-25-005818Jun 9, 2025
- Form 40001225208-25-005817Jun 9, 2025
Fundamentals
XBRL · BATH & BODY WORKS, INC.Annual figures sourced directly from BATH & BODY WORKS, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Bath & Body Works, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 10-QQuarterly reportMay 27, 2026
- 8-KMaterial eventMay 27, 2026
- DEF 14AProxy statementApr 28, 2026
- 10-KANNUAL REPORTMar 12, 2026
- 8-KMaterial eventMar 4, 2026
- 8-KMaterial eventMar 3, 2026
- 8-KMaterial eventFeb 25, 2026
- 10-QQuarterly reportNov 20, 2025
- 8-KMaterial eventNov 20, 2025
- 10-QQuarterly reportAug 28, 2025
- 8-KMaterial eventAug 28, 2025
- 8-KFORM 8-KJun 5, 2025
- 10-QQuarterly reportMay 29, 2025
- 8-KMaterial eventMay 29, 2025
- 8-KFORM 8-KMay 22, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Maverick Capital | Q4 2025 | Q1 2026 | $22 | $24 | +11% |
| Two Sigma Investments | Q3 2025 | open | $28 | $16 | -42% |
| D.E. Shaw | Q3 2025 | open | $28 | $16 | -42% |
| Renaissance Technologies | Q2 2025 | open | $33 | $16 | -51% |
| D1 Capital Partners | Q1 2025 | Q3 2025 | $35 | $28 | -20% |
| Maverick Capital | Q1 2025 | Q2 2025 | $35 | $33 | -6% |
| Citadel Advisors | Q3 2024 | open | $30 | $16 | -46% |
| Two Sigma Investments | Q3 2024 | Q4 2024 | $30 | $30 | +0% |
| D.E. Shaw | Q3 2024 | Q1 2025 | $30 | $35 | +18% |
| AQR Capital Management | Q3 2024 | open | $30 | $16 | -46% |
| Millennium Management | Q3 2024 | open | $30 | $16 | -46% |
| Maverick Capital | Q3 2024 | Q4 2024 | $30 | $30 | +0% |
| Point72 Asset Management | Q3 2024 | open | $30 | $16 | -46% |
| Renaissance Technologies | Q3 2024 | Q1 2025 | $30 | $35 | +17% |
| Bridgewater Associates | Q2 2024 | Q2 2026 | $46 | $17 | -63% |
| Maverick Capital | Q4 2023 | Q2 2024 | $29 | $47 | +60% |
| Third Point | Q4 2022 | Q1 2025 | $30 | $35 | +16% |
| Maverick Capital | Q3 2022 | Q3 2023 | $36 | $35 | -2% |
| Bridgewater Associates | Q3 2022 | Q4 2022 | $36 | $31 | -12% |
| Lone Pine Capital | Q4 2021 | Q4 2024 | $67 | $30 | -56% |
| D1 Capital Partners | Q4 2021 | Q2 2022 | $67 | $44 | -35% |
| Maverick Capital | Q4 2021 | Q2 2022 | $67 | $44 | -35% |
| Coatue Management | Q4 2021 | Q2 2023 | $67 | $31 | -54% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.